Senate designates cholesterol awareness month to address heart disease disparities
S.Res. 464 — A resolution designating September 2025 as "National Cholesterol Education Month" and September 30, 2025, as "LDL-C Awareness Day". · Filed by Cindy Hyde-Smith (R-MS) · 5 cosponsors · Introduced Oct 23, 2025 · Passed chamber
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This resolution designates September 2025 as 'National Cholesterol Education Month' and September 30, 2025, as 'LDL-C Awareness Day' to encourage Americans to know their cholesterol levels and raise awareness about cardiovascular disease prevention. The resolution highlights that elevated LDL cholesterol is a modifiable risk factor for heart disease and stroke, notes disparities in screening and treatment (particularly among African Americans and rural populations), and calls for improved access to cholesterol testing and treatment.
Why we flagged it
This is a straightforward commemorative resolution promoting cardiovascular disease awareness and cholesterol screening. It contains no legislative mechanism, appropriations, or regulatory change—only a designation and encouragement for public health action.
What the text implies
- The resolution's emphasis on screening gaps and disparities (e.g., only 27% of post-heart-attack patients receive LDL-C tests within 90 days; African Americans screened at lower rates) may indirectly pressure healthcare systems and payers to improve access and testing protocols.
- By highlighting that 71% of high-risk hypercholesterolemia patients do not achieve treatment guideline thresholds, the resolution creates a public record of undertreatment that could inform future policy or regulatory action on lipid-lowering therapy access.
Who it affects
Public health awareness campaigns addressing a leading cause of death (cardiovascular disease) benefit ordinary citizens by encouraging preventive screening and treatment, particularly for underserved populations. The resolution highlights care gaps and disparities without imposing costs or restrictions on the public.
Who stands to gain
- pharmaceutical companies (statin and lipid-lowering therapy manufacturers)
- clinical laboratory and diagnostic testing providers
- healthcare systems and cardiology practices
Named in the bill
Senate, Mrs. Hyde-Smith, Mr. Peters, Mr. Boozman, Mr. Marshall, Mr. Daines, Mr. Padilla, Million Hearts program, LDL-C (low-density lipoprotein cholesterol), cardiovascular disease, atherosclerotic cardiovascular disease, statins
Where it stands
5 cosponsors: 3 Republicans, 2 Democrats.
- Oct 23, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- Oct 23, 2025 — Passed the Senate · Congress.gov: “Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the full bill text on Jul 6, 2026; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Senate designates cholesterol awareness month to address heart disease disparities” QuorumCivic. https://share.quorumcivic.app/bill/119/sres464 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.